MLchartDataset catalogue

KAT6 inhibitor PF-07248144

Term · Oncology and biomedicine · MLC-T-ONC-014634

An inhibitor of MYST histone acetyltransferase (HAT) KAT6, with potential antineoplastic activity. Upon administration, KAT6 inhibitor PF-07248144 targets and binds to KAT6, and inhibits the acetylation of histones and other nonhistone substrates. This may disrupt gene expression and inhibit the proliferation of tumors that overexpress KAT6. KAT6A (MOZ; MYST3) and KAT6B (MORF; MOZ2; MYST4), commonly amplified genes in solid tumors, play key roles in cell cycle regulation and in tumorigenesis.

Table 1. Record
IdentifierMLC-T-ONC-014634
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014634",
  "term": "KAT6 inhibitor PF-07248144",
  "field": "Oncology and biomedicine",
  "definition": "An inhibitor of MYST histone acetyltransferase (HAT) KAT6, with potential antineoplastic activity. Upon administration, KAT6 inhibitor PF-07248144 targets and binds to KAT6, and inhibits the acetylation of histones and other nonhistone substrates. This may disrupt gene expression and inhibit the proliferation of tumors that overexpress KAT6. KAT6A (MOZ; MYST3) and KAT6B (MORF; MOZ2; MYST4), commonly amplified genes in solid tumors, play key roles in cell cycle regulation and in tumorigenesis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/kat6-inhibitor-pf-07248144/"
}

Record 9,739 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.